Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Evidence and treatment of skeletal muscle damage to improve the lives of those with Type 1 diabetes
FY 2017-18
Summary
Insulin injections have been used for the management of Type 1 Diabetes, but they are not a cure nor able to prevent disease-related complications. 'Diabetic myopathy,' or skeletal muscle disease, is one such complication and is seen in rodent models of this disease with reduced regenerative and metabolic capacities. However, human diabetic myopathy is largely unstudied. We previously completed a pilot study looking at myopathy in T1D young adults and noted the presence of metabolic complications due to mitochondrial dysfunction. Now, we are interested in determining if this muscle disease worsens with increasing T1D duration.
We hypothesize that skeletal muscle willbe increasingly deteriorated with increasing age and T1D duration and therefore should be treated with clinical relevance. We will use various techniques to look at structural and functional changes in human muscle and mitochondria. Afterwards, we are interested in studying how exercise - one of the best ways to improve health by skeletal muscle adaptation – can restore muscle health in the T1D population. We hypothesize that the current exercise guidelines for those with T1D are severely insufficient for the maintenance of muscle health and overall well-being in T1D persons of all ages.
Overall, the results of this study can provide novel insight on the association between the mitochondria and diabetic myopathy, and then can be immediately clinically translated to T1D complication management and exercise guidelines.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
386478
Name
Varah Nina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evidence and treatment of skeletal muscle damage to improve the lives of those with Type 1 diabetes
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clinical Significance; Damage; Disease Duration; Exercise Guidelines; Metabolic Consequences; Mitochondrial Respiration; Regeneration; Skeletal Muscle; Structural Defects; Type 1 Diabetes
Abstract
Insulin injections have been used for the management of Type 1 Diabetes, but they are not a cure nor able to prevent disease-related complications. 'Diabetic myopathy,' or skeletal muscle disease, is one such complication and is seen in rodent models of this disease with reduced regenerative and metabolic capacities. However, human diabetic myopathy is largely unstudied. We previously completed a pilot study looking at myopathy in T1D young adults and noted the presence of metabolic complications due to mitochondrial dysfunction. Now, we are interested in determining if this muscle disease worsens with increasing T1D duration.
We hypothesize that skeletal muscle willbe increasingly deteriorated with increasing age and T1D duration and therefore should be treated with clinical relevance. We will use various techniques to look at structural and functional changes in human muscle and mitochondria. Afterwards, we are interested in studying how exercise - one of the best ways to improve health by skeletal muscle adaptation – can restore muscle health in the T1D population. We hypothesize that the current exercise guidelines for those with T1D are severely insufficient for the maintenance of muscle health and overall well-being in T1D persons of all ages.
Overall, the results of this study can provide novel insight on the association between the mitochondria and diabetic myopathy, and then can be immediately clinically translated to T1D complication management and exercise guidelines.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Varah, Nina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~